VSee Health, Inc. VSEED
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.79% | 19.89% | 51.61% | 87.97% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.79% | 19.89% | 51.61% | 87.97% | -- |
| Cost of Revenue | 114.26% | 90.77% | 137.37% | 86.52% | -- |
| Gross Profit | -7.84% | -12.14% | 17.77% | 88.76% | -- |
| SG&A Expenses | 15.01% | 26.91% | 91.51% | 188.24% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.08% | 44.28% | 107.27% | 165.35% | -- |
| Operating Income | -47.96% | -98.56% | -325.66% | -576.32% | -- |
| Income Before Tax | 81.07% | 75.86% | 82.81% | -2,087.70% | -- |
| Income Tax Expenses | 104.79% | 104.16% | -94.12% | -89.66% | -- |
| Earnings from Continuing Operations | 80.44% | 75.06% | 82.96% | -1,757.54% | -- |
| Earnings from Discontinued Operations | -317.27% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.37% | 74.50% | 82.42% | -1,742.04% | -- |
| EBIT | -47.96% | -98.56% | -325.66% | -576.32% | -- |
| EBITDA | -55.43% | -99.77% | -337.12% | -353.67% | -- |
| EPS Basic | 88.39% | 82.75% | 84.28% | -959.05% | -- |
| Normalized Basic EPS | 18.57% | -103.16% | -258.89% | 31.00% | -- |
| EPS Diluted | 88.39% | 82.77% | 84.30% | -949.67% | -- |
| Normalized Diluted EPS | 18.57% | -103.16% | -258.89% | 31.00% | -- |
| Average Basic Shares Outstanding | 115.57% | 97.37% | 85.84% | 112.45% | -- |
| Average Diluted Shares Outstanding | 115.57% | 97.37% | 85.84% | 112.45% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |